TrialInternational journal of clinical practice2014

Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER.

S A Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.